You cannot apply for this job anymore (deadline was 2 Mar 2024).
Browse the current job offers or choose an item in the top navigation above.
Research focus
We welcome applications from researchers with a passion for pediatric liver tumors, including hepatoblastoma and hepatocellular carcinoma (HCC), as well as rare metabolic liver diseases in children. Our aim is to understand the molecular profiles of these diseases and to create innovative therapeutic strategies based on these insights.
Innovative Techniques and Collaborative Environment
As a member of our team, you will utilize advanced methodologies such as single-cell and spatial transcriptomics, high-throughput screening, RNA therapy, and antibody engineering. Organoid and mouse models will be used to further our understanding of these treatment modalities. Collaborations with the Single Cell Genomics Facility, Protein and Antibody Facility, High Throughput Screening Facility, and Big Data Core are key to our research, providing a stimulating environment for scientific discovery and progress. Our extensive collaborations both within the Utrecht Science Park and with international institutions foster a dynamic and interdisciplinary research environment. We will align the specific research focus with the postdoctoral researcher’s interests and areas of expertise to ensure a rewarding and mutually beneficial experience.
Fixed-term contract: 1 year, with a possible extension.
We provide a full-time position (36 hours) in a stimulating research environment with ample opportunities for professional development. You will initially be appointed for the duration of one year, with a possible extension. Your gross monthly salary will depend on your experience and background, starting in scale 60 with 8,33% gross monthly salary holiday allowance and 8,33 % end-of-year bonus. The Princess Máxima Center operates according to the collective labor agreement ‘cao algemene ziekenhuizen’.
The Princess Máxima Center for Pediatric Oncology is an integrated hospital and research institute, which integrates healthcare, research and education on pediatric cancer, in a single location in Utrecht. Our institute aims to provide the highest level of care for all children with cancer, with optimal quality of life. The center brings together the best possible care and scientific research, creating a unique interdisciplinary institute for pediatric oncology in Europe.
Our focus is on childhood liver cancer, related diseases, and regenerative medicine. Our goal is to unravel the molecular mechanisms that drive childhood liver cancer and to develop innovative therapeutic approaches. We have previously pioneered the method for 3D hepatocyte organoid culture, and we will continue to leverage this organoid technology to model diseases for therapeutic discovery.
We maken het je graag makkelijk, log in voor deze en andere handige functies: